© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Abecma

Top 10 Cancer Science Highlights of 2021

A look back at some of the most important science and treatment news Cancer Health covered this year.
Chimeric antigen receptor T-cell (CAR-T) therapy

FDA Approves New CAR-T Therapy for Multiple Myeloma

More than 70% of people treated with Abecma, a customized immunotherapy, experienced complete or partial remission.
Advertisement

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.